To understand the chemical basis of action for the PDR5-encoded multidrug resistance transporter of Saccharomyces cerevisiae, we compared the relative hypersensitivities of the wild-type (RW2802) and null mutant strains toward a series of tri-n-alkyltin compounds. These compounds differ from each other in a systematic fashion-either by hydrocarbon chain length or by anion composition. Using zone-of-inhibition and fixed-concentration assays, we found that the ethyl, propyl, and butyl compounds are strong PDR5 substrates, whereas the methyl and pentyl compounds are weak. We conclude that hydrophobicity and anion makeup are relatively unimportant factors in determining whether a tri-n-alkyltin compound is a good PDR5 substrate but that the dissociation of the compound and the molecular size are significant.The yeast PDR5 gene encodes a 160-kDa protein that is a member of the ATP-binding cassette transport superfamily (1). Loss-of-function mutations in this gene create broad-spectrum hypersensitivity to a large array of chemically diverse inhibitors because of an inability to cause efflux of such compounds (11). Overexpression of the PDR5 gene product, in contrast, results in multidrug resistance (MDR) (1,14). As is the case for most of the other MDR proteins encountered in eucaryotes, the chemical basis for the broad specificities of the PDR5 transporter remains unknown. Precise knowledge of the mechanism by which transporters recognize their substrates might have important clinical ramifications. Furthermore, it could help explain the basis for the interesting classes of MDR mutants with altered specificities that have been identified for yeast (3) and mammalian (6, 12) cells.Most models of MDR action invoke the requirement of hydrophobicity (5). This idea is based upon the fact that several structurally related drugs that differ in their ability to be transported by the mammalian MDR transporter differ in their relative hydrophobicities, as measured by their water/octanol partitioning ratio (logP) (15,18). This observation was used as evidence for proposing that the mammalian MDR protein is a flippase. Thus, a drug must be intercalated into the lipid bilayer before it interacts with a binding site on the efflux protein (5).To address various models of PDR5 substrate recognition, we analyzed the abilities of the wild-type and isogenic null mutant proteins to mediate resistance toward a family of structurally related tri-n-alkyltin compounds that interfere with mitochondrial ATPase activity (2) and differ systematically either by the length of the hydrocarbon chain or by the counterion. Zoneof-inhibition and fixed-concentration assays were used so that quantitative comparisons could be made with a high degree of accuracy. The results obtained were compared to measures of hydrophobicity, ion dissociation, and molecular size.
MATERIALS AND METHODSYeast strains. The two isogenic strains of Saccharomyces cerevisiae used in this study were previously described (11). RW2802 contains a functional PDR5 gene, while JG436 ha...